Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 CAD | +9.52% | +7.48% | -17.86% |
09/04 | Transcript : Medicure Inc., 2023 Earnings Call, Apr 09, 2024 | |
08/04 | Medicure Swung to a Loss in 2023 on Lower Sales | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 95.56 | 47.54 | 12.44 | 9.431 | 10.35 | 14.61 |
Enterprise Value (EV) 1 | 23.67 | 35.66 | 11.17 | 6.906 | 6.346 | 8.786 |
P/E ratio | 25.6 x | -3.33 x | -1.86 x | -13 x | 7.71 x | -15.6 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 3.28 x | 2.36 x | 1.07 x | 0.43 x | 0.45 x | 0.67 x |
EV / Revenue | 0.81 x | 1.77 x | 0.96 x | 0.32 x | 0.28 x | 0.4 x |
EV / EBITDA | -25.5 x | -5.49 x | -2.18 x | 19.1 x | 2.21 x | 9.42 x |
EV / FCF | 0.37 x | -1.56 x | 2.66 x | 6.01 x | 4.87 x | 3.73 x |
FCF Yield | 270% | -64% | 37.6% | 16.6% | 20.5% | 26.8% |
Price to Book | 1.14 x | 1.76 x | 0.64 x | 0.51 x | 0.49 x | 0.73 x |
Nbr of stocks (in thousands) | 15,538 | 10,804 | 10,451 | 10,251 | 10,251 | 10,436 |
Reference price 2 | 6.150 | 4.400 | 1.190 | 0.9200 | 1.010 | 1.400 |
Announcement Date | 29/04/19 | 16/04/20 | 20/04/21 | 27/04/22 | 06/04/23 | 08/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 29.11 | 20.17 | 11.61 | 21.74 | 23.06 | 21.69 |
EBITDA 1 | -0.927 | -6.501 | -5.132 | 0.361 | 2.873 | 0.933 |
EBIT 1 | -1.226 | -8.147 | -7.686 | -2.495 | 1.193 | -0.854 |
Operating Margin | -4.21% | -40.39% | -66.2% | -11.47% | 5.17% | -3.94% |
Earnings before Tax (EBT) 1 | 4.823 | -19.64 | -6.845 | -0.759 | 1.385 | -0.897 |
Net income 1 | 3.926 | -19.79 | -6.845 | -0.727 | 1.365 | -0.922 |
Net margin | 13.49% | -98.08% | -58.96% | -3.34% | 5.92% | -4.25% |
EPS 2 | 0.2400 | -1.320 | -0.6406 | -0.0709 | 0.1310 | -0.0900 |
Free Cash Flow 1 | 63.92 | -22.83 | 4.2 | 1.15 | 1.303 | 2.353 |
FCF margin | 219.58% | -113.19% | 36.18% | 5.29% | 5.65% | 10.85% |
FCF Conversion (EBITDA) | - | - | - | 318.49% | 45.37% | 252.18% |
FCF Conversion (Net income) | 1,628.22% | - | - | - | 95.49% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 29/04/19 | 16/04/20 | 20/04/21 | 27/04/22 | 06/04/23 | 08/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 71.9 | 11.9 | 1.27 | 2.53 | 4.01 | 5.83 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 63.9 | -22.8 | 4.2 | 1.15 | 1.3 | 2.35 |
ROE (net income / shareholders' equity) | 4.78% | -35.8% | -29.7% | -3.87% | 6.93% | -4.51% |
ROA (Net income/ Total Assets) | -0.66% | -6.97% | -12.6% | -4.99% | 2.56% | -1.84% |
Assets 1 | -596 | 283.8 | 54.39 | 14.56 | 53.37 | 50.06 |
Book Value Per Share 2 | 5.380 | 2.490 | 1.870 | 1.800 | 2.050 | 1.910 |
Cash Flow per Share 2 | 1.550 | 1.200 | 0.2600 | 0.3600 | 0.4700 | 0.6100 |
Capex 1 | 0.2 | 0.19 | 0 | 0.38 | 0.01 | - |
Capex / Sales | 0.68% | 0.92% | 0.02% | 1.73% | 0.06% | - |
Announcement Date | 29/04/19 | 16/04/20 | 20/04/21 | 27/04/22 | 06/04/23 | 08/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-17.86% | 8.78M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MPH Stock
- Financials Medicure Inc.